Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Web-Enhanced Guideline Implementation for Post MI CBOC Patients (VA MI Plus)

24. juni 2015 opdateret af: US Department of Veterans Affairs

MI-Plus: Web-enhanced Guideline Implementation for Post MI CBOC Patients

To assist busy primary care clinicians in VA Community Based Outpatient Clinics (CBOCs) in managing complex patients by providing a single, interactive, and personalized source of information regarding applicable guidelines for post-MI patients. Specifically, 1) the investigators will identify barriers to provider adherence to guidelines within VHA clinics; 2) Apply guideline-based performance measures to electronic medical records (CPRS) and associated administrative data; 3) Implement the interactive Internet intervention developed by the NHLBI study, after inclusion of VA-specific components, including performance feedback for CBOC clinicians; and 4) Test hypotheses on the intervention's effectiveness, sustainability, and cost-effectiveness in both the VA and Medicare populations. This will include a randomized controlled trial with the CBOC as a unit of randomization.

Studieoversigt

Status

Afsluttet

Detaljeret beskrivelse

Some 7.1 million Americans and an estimated 250,000 Veterans actively using VHA are Myocardial Infarction (MI) survivors. To date, most guideline interventions focus on a single patient condition, but ambulatory post-MI patients are frequently more complex, multiple comorbidities, and conflicting guidelines applicable to them. For example, whereas JNC-6 guidelines for the treatment of hypertension suggest pharmacological treatment at blood pressures above 140/80 mm Hg, to be initiated with diuretics or beta-blockers as first line agents, other guidance suggests that for post-MI patients with diabetes, treatment cut-offs should be lower and ACE-inhibitors may be considered as optimal first-line agents. On October 1, 2002, the University of Alabama at Birmingham (UAB) began a study funded by the National Heart, Lung, and Blood institute (NHLBI) as an RO1 (Kiefe, PI (25%), Weissman, co-PI (20%)) to conduct a randomized trial, MI-plus to increase provider adherence to guidelines for post-MI patients. That NHLBI-funded study targets Medicare beneficiaries and their primary care providers in Alabama. Its primary goal is to develop and test with a randomized controlled trial, an Internet-based multimodal guideline implementation strategy. The investigators propose, herewith, to extend and adapt this study to a nationwide sample of VA post-MI patients and their primary care providers in the VA.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

847

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forenede Stater, 35233
        • VA Medical Center, Birmingham
    • Arizona
      • Phoenix, Arizona, Forenede Stater, 85012
        • Carl T. Hayden VA Medical Center
    • Arkansas
      • Fayetteville, Arkansas, Forenede Stater, 72703
        • Fayetteville, AR
    • California
      • Long Beach, California, Forenede Stater, 90822
        • Long Beach
      • San Francisco, California, Forenede Stater, 94121
        • VA Medical Center
    • Connecticut
      • West Haven, Connecticut, Forenede Stater, 06516
        • VA Connecticut Health Care System (West Haven)
    • Florida
      • Bay Pines, Florida, Forenede Stater, 33708
        • Bay Pines VA Healthcare System, Pay Pines, FL
      • Miami, Florida, Forenede Stater, 33125
        • VA Medical Center, Miami
    • Georgia
      • Decatur, Georgia, Forenede Stater, 30033
        • VA Medical Center, Decatur
    • Illinois
      • Chicago, Illinois, Forenede Stater, 60612
        • Jesse Brown VAMC (WestSide Division)
      • Danville, Illinois, Forenede Stater, 61832
        • VA Illiana Health Care System
    • Iowa
      • Iowa City, Iowa, Forenede Stater, 52246
        • VA Medical Center Iowa City
    • Kansas
      • Topeka, Kansas, Forenede Stater, 66622
        • VA Eastern Kansas Health Care System - Topeka
      • Wichita, Kansas, Forenede Stater, 67218
        • Robert J. Dole VAMC & ROC
    • Kentucky
      • Louisville, Kentucky, Forenede Stater, 40206
        • VA Medical Center, Louisville
    • Louisiana
      • Shreveport, Louisiana, Forenede Stater, 71101
        • Overton Brooks VA Medical Center, Shreveport, LA
    • Massachusetts
      • Bedford, Massachusetts, Forenede Stater, 01730
        • Edith Nourse Rogers Memorial Veterans Hospital
      • Boston, Massachusetts, Forenede Stater, 02130
        • VA Boston Health Care System, Jamaica Plain
    • Michigan
      • Ann Arbor, Michigan, Forenede Stater, 48105
        • VA Ann Arbor Healthcare System
      • Battle Creek, Michigan, Forenede Stater, 49015
        • Battle Creek, MI
    • Mississippi
      • Biloxi, Mississippi, Forenede Stater, 39531
        • VA Gulf Coast Veterans Health Care System
    • Missouri
      • Columbia, Missouri, Forenede Stater, 65201-5297
        • Harry S. Truman Memorial VA Medical Center
      • Kansas City, Missouri, Forenede Stater, 64128
        • Kansas City VA Medical Center
      • St Louis, Missouri, Forenede Stater, 63106
        • VA Medical Center, St Louis
    • New Jersey
      • East Orange, New Jersey, Forenede Stater, 07018
        • VA New Jersey Health Care System, East Orange
    • New York
      • Albany, New York, Forenede Stater, 12208
        • Albany VA Medical Center: Samuel S. Stratton
      • Albany, New York, Forenede Stater, 12208
        • No Longer Valid, Use 528A8
      • Montrose, New York, Forenede Stater, 10548
        • Franklin Delano Roosevelt Campus of VAHVHCS
      • New York, New York, Forenede Stater, 10010
        • New York, NY
    • Ohio
      • Cincinnati, Ohio, Forenede Stater, 45220
        • VA Medical Center, Cincinnati
      • Cleveland, Ohio, Forenede Stater, 44106-3800
        • VA Medical Center, Cleveland
    • Pennsylvania
      • Coatesville, Pennsylvania, Forenede Stater, 19320
        • Coatesville, PA
      • Lebanon, Pennsylvania, Forenede Stater, 17042
        • Lebanon, PA
    • Rhode Island
      • Providence, Rhode Island, Forenede Stater, 02908-4799
        • VA Medical Center, Providence
    • South Carolina
      • Charleston, South Carolina, Forenede Stater, 29401-5799
        • Ralph H Johnson VA Medical Center, Charleston
    • Tennessee
      • Nashville, Tennessee, Forenede Stater, 37212-2637
        • VA Medical Center
    • Utah
      • Salt Lake City, Utah, Forenede Stater, 84148
        • VA Salt Lake City Health Care System, Salt Lake City
    • Vermont
      • White River Junction, Vermont, Forenede Stater, 05009-0001
        • VA Medical & Regional Office Center, White River
    • Wisconsin
      • Madison, Wisconsin, Forenede Stater, 53705
        • William S. Middleton Memorial Veterans Hospital
      • Milwaukee, Wisconsin, Forenede Stater, 53295-1000
        • Clement J. Zablocki VAMC
      • San Juan, Puerto Rico, 00921-3201
        • San Juan Vamc

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn
  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

Potential subjects are defined as any VA-employed physician, PA, or CRNP who is a CBOC provider. All such providers will be offered the opportunity to participate and will have the option to agree to participate or not. Performance measure data from records of post-MI patients of the above providers will be extracted to test the experimental intervention. (Note: No individually identifying patient information will be extracted.) All VA-employed CBOC providers (physicians, PAs, CRNPs) will be offered the opportunity to participate in this study. Any subject may refuse to participate or to discontinue participation at will at any point in the study without consequence.

Exclusion Criteria:

Potential subjects must be VA-employed physician, PA, or CRNP who is a CBOC provider. No such healthcare providers will be excluded from the study.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Sundhedstjenesteforskning
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Andet: Arm 1
The experimental intervention, customized to the individual clinician in real-time consists of Internet learning modules integrating case-based education with audit, feedback, and benchmarking of practice profiles.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Primary Outcome Was the Performance of Each Provider on Each of Seven Clinical Indicators
Tidsramme: 1/1/02 - 12/31/08
The investigators used an intent-to-treat approach for our main analysis, basing our outcome measures on provider's eligible patient population in each of the clinics. Performance improvement was calculated at the change (before vs after the intervention) the percentage of provider's patients with each clinical indicator. 1) change in the percentage of patients with improvements in LDL. Improvement defined as LDL-C level < previous 18 mos; 2) Change in the percentage of patients with improvements in A1c. Improvement defined as HbA1c level < previous 18 mos; 3) Change in percentage of patients prescribed Beta Blockers; 4) Change in the percentage of patients prescribed Statins; 5) Change in the percentage of patients prescribed ACEI or ARB; 6) Change in percentage of patients reaching target goal for LDL-C (<100mg/dL); 7) Change in percentage of patients reaching target goal for HbA1c (<8%).
1/1/02 - 12/31/08

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Thomas K Houston, MD MPH, Edith Nourse Rogers Memorial Veterans Hospital, Bedford
  • Ledende efterforsker: Ellen Funkhouser, DrPH MS BS, VA Medical Center, Birmingham

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. september 2003

Primær færdiggørelse (Faktiske)

1. juni 2010

Studieafslutning (Faktiske)

1. juni 2010

Datoer for studieregistrering

Først indsendt

2. august 2005

Først indsendt, der opfyldte QC-kriterier

2. august 2005

Først opslået (Skøn)

4. august 2005

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

23. juli 2015

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

24. juni 2015

Sidst verificeret

1. juni 2015

Mere information

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner